tiprankstipranks
Trending News
More News >
Clearside Biomedical Inc (CLSD)
:CLSD
US Market

Clearside Biomedical (CLSD) Income Statement

Compare
1,007 Followers

Clearside Biomedical Income Statement

Last quarter (Q3 2024), Clearside Biomedical's total revenue was $1.04M, an increase of 20.84% from the same quarter last year. In Q3, Clearside Biomedical's net income was $-7.69M. See Clearside Biomedical’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 8.23M$ 1.33M$ 29.57M$ 7.89M
Gross Profit
$ 0.00$ 7.87M$ 1.12M$ 29.40M$ 7.89M
Operating Expenses
$ 30.55M$ 32.72M$ 31.40M$ 30.20M$ 25.83M
Depreciation and Amortization
$ 0.00$ 67.00K$ 145.00K$ 178.00K$ 180.00K
EBITDA
$ -28.88M$ -23.06M$ -29.46M$ -449.00K$ -17.93M
Operating Income
$ -28.88M$ -24.84M$ -30.28M$ -627.00K$ -17.93M
Other Income/Expenses
$ -5.47M$ -7.64M$ -2.67M$ 1.00M$ -275.00K
Pretax Income
$ -34.35M$ -32.48M$ -32.95M$ 376.00K$ -18.21M
Net Income
$ -34.35M$ -32.48M$ -34.07M$ 376.00K$ -18.03M
Per Share Metrics
Basic EPS
$ -0.47$ -0.53$ -0.57$ 0.01$ -0.39
Diluted EPS
$ -0.47$ -0.53$ -0.57$ 0.01$ -0.39
Weighted Average Shares Outstanding
73.80M 61.81M 60.20M 58.49M 46.51M
Weighted Average Shares Outstanding (Diluted)
73.80M 61.81M 60.20M 59.91M 46.51M
Currency in USD

Clearside Biomedical Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis